Enanta Pharmaceuticals | ENTA - Caixa e Equivalentes





Caixa e Equivalentes Alterar Data
AbbVie USD 6.57B 2.82B 2026-06
Amgen USD 13.99B 1.95B 2026-06
Anika Therapeutics USD 38.41M 2.61M 2026-06
Arrowhead Research USD 19.68M 127.85M 2026-06
AstraZeneca USD 4.89B 2.67B 2026-06
BioCryst Pharmaceuticals USD 154.97M 16.62M 2026-06
Biogen USD 1.28B 2.1B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Enanta Pharmaceuticals USD 37.44M 5.14M 2025-12
Gilead Sciences USD 7.63B 64M 2026-03
GlaxoSmithKline GBP 3.44B 292M 2026-03
Halozyme Therapeutics USD 163.14M 146.61M 2026-06
Heron Therapeutics USD 20.72M 5.4M 2026-06
Immunic USD 186.63M 171.15M 2026-03
Incyte USD 3.98B 33.45M 2026-06
Insmed USD 544.76M 37.42M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
J&J USD 20.42B 1.27B 2026-06
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
Ligand Pharmaceuticals USD 1.01B 891.62M 2026-06
Merck USD 6.85B 1.52B 2026-06
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Novartis USD 7.62B 739M 2026-06
Novavax USD 191.46M 36.9M 2026-06
Pfizer USD 976M 727M 2026-06
PTC Therapeutics USD 1.05B 215.9M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06